These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 11353640

  • 1. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P, Yardley V, Croft SL.
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
    [Abstract] [Full Text] [Related]

  • 2. In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.
    Kumar D, Kulshrestha A, Singh R, Salotra P.
    Antimicrob Agents Chemother; 2009 Feb; 53(2):835-8. PubMed ID: 19015344
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
    Seifert K, Croft SL.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
    [Abstract] [Full Text] [Related]

  • 4. Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.
    Sharief AH, Gasim Khalil EA, Theander TG, Kharazmi A, Omer SA, Ibrahim ME.
    Exp Parasitol; 2006 Dec; 114(4):247-52. PubMed ID: 16716301
    [Abstract] [Full Text] [Related]

  • 5. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
    Bhattacharya S, Ghosh P, De T, Gomes A, Gomes A, Dungdung SR.
    Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
    [Abstract] [Full Text] [Related]

  • 6. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD, Saha B, Chattopadhyay A.
    Biochem Biophys Res Commun; 2010 Aug 27; 399(3):429-33. PubMed ID: 20678487
    [Abstract] [Full Text] [Related]

  • 7. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
    Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK, Bhattacharya SK.
    Natl Med J India; 2005 Aug 27; 18(3):131-3. PubMed ID: 16130613
    [Abstract] [Full Text] [Related]

  • 8. [A case of antimony resistant kala-azar cured with amphotericin B].
    Chen SB, Yang CM, Zhang CJ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun 27; 25(3):inside front page. PubMed ID: 18038767
    [No Abstract] [Full Text] [Related]

  • 9. In vitro interactions between sitamaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani.
    Seifert K, Munday J, Syeda T, Croft SL.
    J Antimicrob Chemother; 2011 Apr 27; 66(4):850-4. PubMed ID: 21393188
    [Abstract] [Full Text] [Related]

  • 10. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
    Dube A, Singh N, Sundar S, Singh N.
    Parasitol Res; 2005 Jun 27; 96(4):216-23. PubMed ID: 15868188
    [Abstract] [Full Text] [Related]

  • 11. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.
    Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R.
    Microbiol Spectr; 2024 Jun 04; 12(6):e0402623. PubMed ID: 38712926
    [Abstract] [Full Text] [Related]

  • 12. Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovani.
    Petit C, Yardley V, Gaboriau F, Bolard J, Croft SL.
    Antimicrob Agents Chemother; 1999 Feb 04; 43(2):390-2. PubMed ID: 9925541
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model.
    Utaile M, Kassahun A, Abebe T, Hailu A.
    Exp Parasitol; 2013 May 04; 134(1):68-75. PubMed ID: 23434530
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.
    Vermeersch M, da Luz RI, Toté K, Timmermans JP, Cos P, Maes L.
    Antimicrob Agents Chemother; 2009 Sep 04; 53(9):3855-9. PubMed ID: 19546361
    [Abstract] [Full Text] [Related]

  • 15. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P, Parmar N, Yadav PK, Chandrakar P, Kar S.
    J Mol Med (Berl); 2016 Jun 04; 94(6):695-710. PubMed ID: 26830627
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
    Pal S, Ravindran R, Ali N.
    Antimicrob Agents Chemother; 2004 Sep 04; 48(9):3591-3. PubMed ID: 15328135
    [Abstract] [Full Text] [Related]

  • 17. Responses to Leishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase.
    Murray HW, Xiang Z, Ma X.
    Am J Trop Med Hyg; 2006 Jun 04; 74(6):1013-5. PubMed ID: 16760512
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of visceral leishmaniasis in children].
    Minodier P, Noël G, Blanc P, Uters M, Retornaz K, Garnier JM.
    Med Trop (Mars); 2007 Feb 04; 67(1):73-8. PubMed ID: 17506279
    [Abstract] [Full Text] [Related]

  • 19. The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis.
    Carter KC, Sundar S, Spickett C, Pereira OC, Mullen AB.
    Antimicrob Agents Chemother; 2003 May 04; 47(5):1529-35. PubMed ID: 12709318
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
    Seifert K, Pérez-Victoria FJ, Stettler M, Sánchez-Cañete MP, Castanys S, Gamarro F, Croft SL.
    Int J Antimicrob Agents; 2007 Sep 04; 30(3):229-35. PubMed ID: 17628445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.